Acute and repeated cocaine induces alterations in FosB/ΔFosB expression in the paraventricular nucleus of the hypothalamus

Brain Research

Volumn 1090, Issue 1, 2006, Pages 58-68

  Chocyk, Agnieszka ^a   Czyrak, Anna ^a   Wedzony, Krzysztof ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

FosB; Cocaine; CRF; Dopamine D1 receptor; FosB; PVN

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; TRANSCRIPTION FACTOR DELTA FOSB; TRANSCRIPTION FACTOR FOSB;

ADDICTION; ANIMAL CELL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MOLECULAR MECHANICS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN CHEMISTRY; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; REWARD; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

EID: 33744518552     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.045     Document Type: Article

References (63)

1. Akil H., Campeau S., Cullinan W.E., Lechan R.M., Toni R., Watson S.J., and Moore R.Y. Neuroendocrine system I: Overview-Thyroid and adrenal axes. In: Zigmond M.J., Bloom F.E., Landies S.C., Roberts J.L., and Squire L.R. (Eds). Fundamental Neuroscience (1999), Academic Press 1127-1147
2. Alonso G., Szafarczyk A., and Assenmacher I. Immunoreactivity of hypothalamo-neurohypophysial neurons which secrete corticotropin-releasing hormone (CRH) and vasopressin (Vp): immunocytochemical evidence for a correlation with their functional state in colchicine-treated rats. Exp. Brain Res. 61 (1986) 497-505
3. Andersson M., Konradi C., and Cenci M.A. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J. Neurosci. 21 (2001) 9930-9943
4. Aoki C., Go C.G., Venkatesan C., and Kurose H. Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. Brain Res. 650 (1994) 181-204
5. Armstrong W.E. Hypothalamic supraoptic and paraventricular nuclei. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press 377-390
6. Bartanusz V., Muller D., Gaillard R.C., Streit P., Vutskits L., and Kiss J.Z. Local gamma-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus. Eur. J. Neurosci. 19 (2004) 777-782
7. Beveridge T.J., Smith H.R., Nader M.A., and Porrino L.J. Functional effects of cocaine self-administration in primate brain regions regulating cardiovascular function. Neurosci.Lett. 370 (2004) 201-205
8. Borowsky B., and Kuhn C.M. Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res. 543 (1991) 301-306
9. Borowsky B., and Kuhn C.M. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J. Pharmacol. Exp. Ther. 256 (1991) 204-210
10. Calogero A.E., Gallucci W.T., Kling M.A., Chrousos G.P., and Gold P.W. Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 505 (1989) 7-11
11. Chen J., Nye H.E., Kelz M.B., Hiroi N., Nakabeppu Y., Hope B.T., and Nestler E.J. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. 48 (1995) 880-889
12. Chen J., Kelz M.B., Hope B.T., Nakabeppu Y., and Nestler E.J. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J. Neurosci. 17 (1997) 4933-4941
13. Cheung S., Ballew J.R., Moore K.E., and Lookingland K.J. Contribution of dopamine neurons in the medial zona incerta to the innervation of the central nucleus of the amygdala, horizontal diagonal band of Broca and hypothalamic paraventricular nucleus. Brain Res. 808 (1998) 174-181
14. Ciliax B.J., Nash N., Heilman C., Sunahara R., Hartney A., Tiberi M., Rye D.B., Caron M.G., Niznik H.B., and Levey A.I. Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37 (2000) 125-145
15. Clouet D. NIDA Research Monograph 88: mechanisms of cocaine abuse and toxicity (1988), NIDA, Rockvile, MD
16. Cole R.L., and Sawchenko P.E. Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J. Neurosci. 22 (2002) 959-969
17. Contoreggi C., Herning R.I., Koeppl B., Simpson P.M., Negro Jr. P.J., Fortner-Burton C., and Hess J. Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion. Neuroendocrinology 78 (2003) 154-162
18. Crespo J.A., Manzanares J., Oliva J.M., Corchero J., Garcia-Lecumberri C., and Ambrosio E. Extinction of cocaine self-administration produces alterations in corticotropin releasing factor gene expression in the paraventricular nucleus of the hypothalamus. Mol. Brain Res. 117 (2003) 160-167
19. Czyrak A., Chocyk A., Mackowiak M., Fijal K., and Wedzony K. Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. Mol. Brain Res. 85 (2000) 209-217
20. Daftary S.S., Boudaba C., Szabo K., and Tasker J.G. Noradrenergic excitation of magnocellular neurons in the rat hypothalamic paraventricular nucleus via intranuclear glutamatergic circuits. J. Neurosci. 18 (1998) 10619-10628
21. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 Suppl. 1 (2004) 227-241
22. Fetissov S.O., Meguid M.M., Sato T., and Zhang L.H. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 283 (2002) R905-R910
23. Fremeau Jr. R.T., Duncan G.E., Fornaretto M.G., Dearry A., Gingrich J.A., Breese G.R., and Caron M.G. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3772-3776
24. Galici R., Pechnick R.N., Poland R.E., and France C.P. Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats. Eur. J. Pharmacol. 387 (2000) 59-62
25. Heesch C.M., Negus B.H., Keffer J.H., Snyder R.W., Risser R.C., and Eichhorn E.J. Effects of cocaine on cortisol secretion in humans. Am. J. Med. Sci. 310 (1995) 61-64
26. Herdegen T., and Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28 (1998) 370-490
27. Iversen S., Iversen L., and Saper C.B. The autonomic nervous system and the hypothalamus. In: Kandel J.H., and Schwartz T.M. (Eds). Principle of Neural Science (2000), McGraw-Hill 960-981
28. Kiritsy-Roy J.A., Halter J.B., Gordon S.M., Smith M.J., and Terry L.C. Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J. Pharmacol. Exp. Ther. 255 (1990) 154-160
29. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
30. Mackowiak M., Chocyk A., Fijal K., Czyrak A., and Wedzony K. c-Fos proteins, induced by the serotonin receptor agonist DOI, are not expressed in 5-HT2A positive cortical neurons. Mol. Brain Res. 71 (1999) 358-363
31. Mantsch J.R., Yuferov V., Mathieu-Kia A.M., Ho A., and Kreek M.J. Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. Psychoneuroendocrinology 28 (2003) 836-862
32. McClung C.A., and Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6 (2003) 1208-1215
33. Mello N.K., and Mendelson J.H. Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol. Biochem. Behav. 57 (1997) 571-599
34. Mendelson J.H., Sholar M., Mello N.K., Teoh S.K., and Sholar J.W. Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 18 (1998) 263-271
35. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Mutschler N., and Halpern J. Temporal concordance of cocaine effects on mood states and neuroendocrine hormones. Psychoneuroendocrinology 27 (2002) 71-82
36. Moor K.E., and Lookingland K.J. Dopaminergic neuronal systems in the hypothalamus. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), RavenPress, New York 245-256
37. Moratalla R., Elibol B., Vallejo M., and Graybiel A.M. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17 (1996) 147-156
38. Moratalla R., Vallejo M., Elibol B., and Graybiel A.M. D1-class dopamine receptors influence cocaine-induced persistent expression of Fos-related proteins in striatum. NeuroReport 8 (1996) 1-5
39. Muller D.L., and Unterwald E.M. D1 dopamine receptors modulate {delta}FosB induction in rat striatum after intermittent morphine administration. J. Pharmacol. Exp. Ther. 314 (2005) 148-154
40. Nestler E.J., Barrot M., and Self D.W. DeltaFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11042-11046
41. Nicholson R.C., King B.R., and Smith R. Complex regulatory interactions control CRH gene expression. Front. Biosci. 9 (2004) 32-39
42. Nye H.E., Hope B.T., Kelz M.B., Iadarola M., and Nestler E.J. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275 (1995) 1671-1680
43. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press
44. Perrotti L.I., Bolanos C.A., Choi K.H., Russo S.J., Edwards S., Ulery P.G., Wallace D.L., Self D.W., Nestler E.J., and Barrot M. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur. J. Neurosci. 21 (2005) 2817-2824
45. Piazza P.V., Deroche V., Deminiere J.M., Maccari S., Le Moal M., and Simon H. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11738-11742
46. Reyes B.A., Valentino R.J., Xu G., and Van Bockstaele E.J. Hypothalamic projections to locus coeruleus neurons in rat brain. Eur. J. Neurosci. 22 (2005) 93-106
47. Rivier C., and Lee S. Stimulatory effect of cocaine on ACTH secretion: role of the hypothalamus. Mol. Cell. Neurosci. 5 (1994) 189-195
48. Rivier C., and Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422 (1987) 403-406
49. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53 (2001) 209-243
50. Schmidt E.D., Tilders F.J., Janszen A.W., Binnekade R., De Vries T.J., and Schoffelmeer A.N. Intermittent cocaine exposure causes delayed and long-lasting sensitization of cocaine-induced ACTH secretion in rats. Eur. J. Pharmacol. 285 (1995) 317-321
51. Shepard J.D., Liu Y., Sassone-Corsi P., and Aguilera G. Role of glucocorticoids and cAMP-mediated repression in limiting corticotropin-releasing hormone transcription during stress. J. Neurosci. 25 (2005) 4073-4081
52. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology 158 (2001) 343-359
53. Sofroniew M.V. Vasopressin, oxytocin and their related neurophysins. In: Bjorklund A., and Hokfelt T. (Eds). Handbook of Chemical Neuroanatomy. GABA and Neuropeptides in the CNS, Part I vol. 4 (1985), Elsevier Science 93-153
54. Swanson L.W., and Kuypers H.G.J.M. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J. Comp. Neurol. 194 (1980) 555-570
55. Teoh S.K., Sarnyai Z., Mendelson J.H., Mello N.K., Springer S.A., Sholar J.W., Wapler M., Kuehnle J.C., and Gelles H. Cocaine effects on pulsatile secretion of ACTH in men. J. Pharmacol. Exp. Ther. 270 (1994) 1134-1138
56. Torres G., and Horowitz J.M. Drugs of abuse and brain gene expression. Psychosom. Med. 61 (1999) 630-650
57. Uhl G.R., Hall F.S., and Sora I. Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 7 (2002) 21-26
58. Wagner C.K., Eaton M.J., Moore K.E., and Lookingland K.J. Efferent projections from the region of the medial zona incerta containing A13 dopaminergic neurons: a PHA-L anterograde tract-tracing study in the rat. Brain Res. 677 (1995) 229-237
59. Zhang Y., Gray T.S., D'Souza D.N., Carrasco G.A., Damjanoska K.J., Dudas B., Garcia F., Zainelli G.M., Sullivan Hanley N.R., Battaglia G., Muma N.A., and Van de Kar L.D. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo. J. Pharmacol. Exp. Ther. 310 (2004) 59-66
60. Zhou Y., Spangler R., LaForge K.S., Maggos C.E., Ho A., and Kreek M.J. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. J. Pharmacol. Exp. Ther. 279 (1996) 351-358
61. Zhou Y., Spangler R., Ho A., and Jeanne K.M. Hypothalamic CRH mRNA levels are differentially modulated by repeated 'binge' cocaine with or without D(1) dopamine receptor blockade. Mol. Brain Res. 94 (2001) 112-118
62. Zhou Y., Spangler R., Schlussman S.D., Ho A., and Kreek M.J. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal. Brain Res. 964 (2003) 187-199
63. Zhou Y., Spangler R., Yuferov V.P., Schlussmann S.D., Ho A., and Kreek M.J. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus. Mol. Brain Res. 130 (2004) 61-67